FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Teva Pharmaceuticals Amethyst Recall

Amethyst (Levonorgestrel and Ethinyl Estradiol Tablets USP, 90mcg/20mcg), 28 tablet di…

Teva Pharmaceuticals USA · North Wales, PA

Risk level
Class II
Reported by FDA
Dec 27, 2017
Recall ID
D-0125-2018
Check your lot numberHow we source this data

Summary

Teva Pharmaceuticals recalled Amethyst starting Nov 20, 2017. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0125-2018 on Dec 27, 2017. Reason: Labeling: Incorrect Instructions. "TABLETS IN WEEK 4 ARE INACTIVE" printed on the blister foil and package insert, however,all tablets are active. Status: Terminated.

Why it was recalled

Labeling: Incorrect Instructions. "TABLETS IN WEEK 4 ARE INACTIVE" printed on the blister foil and package insert, however,all tablets are active.

Product description

Amethyst (Levonorgestrel and Ethinyl Estradiol Tablets USP, 90mcg/20mcg), 28 tablet dispenser (blister foil unit), Rx only, Manufactured by: Warner Chilcott Company, LLC Fajardo, Puerto Rico 00738: Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054 USA, NDC-52544-295-28

Lot numbers, UPCs & expiration codes

Lot # 544637A

Where it was sold

Nationwide in the USA and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0125-2018
Classification
Class II
Status
Terminated
Recall initiated
Nov 20, 2017
FDA report date
Dec 27, 2017
Quantity
5,374 blister cards/28 tablets
Recall type
Voluntary: Firm initiated
Recalling firm
Teva Pharmaceuticals USA

Original FDA data

Every field from FDA enforcement report D-0125-2018, exactly as published.

Show all FDA fields
City
North Wales
State
PA
Status
Terminated
Country
United States
Event ID
78590
Address
1090 Horsham Rd
Code information
Lot # 544637A
Postal code
19454-1505
Report date
Dec 27, 2017
Product type
Drugs
Recall number
D-0125-2018
Classification
Class II
Recalling firm
Teva Pharmaceuticals USA
Product quantity
5,374 blister cards/28 tablets
Termination date
Jun 21, 2018
Reason for recall
Labeling: Incorrect Instructions. "TABLETS IN WEEK 4 ARE INACTIVE" printed on the blister foil and package insert, however,all tablets are active.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Amethyst (Levonorgestrel and Ethinyl Estradiol Tablets USP, 90mcg/20mcg), 28 tablet dispenser (blister foil unit), Rx only, Manufactured by: Warner Chilcott Company, LLC Fajardo, Puerto Rico 00738: Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054 USA, NDC-52544-295-28
Distribution pattern
Nationwide in the USA and Puerto Rico
Recall initiation date
Nov 20, 2017
Initial firm notification
Letter
Center classification date
Dec 20, 2017

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0125-2018, published Dec 27, 2017. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls